SOSOROS FUND MANAGEMENT LLC
Institutional investor · Portfolio as of Q1 2023
Top Holdings185 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
HORIZON THERAPEUTICS PLC | 3.3M | $359.3M | 5.5% | — | — | 2 qtrssince 2022-Q4 | Increased 69 |
ISHARES IBOXX INVESTMENT GRA | 2.4M | $265.6M | 4.1% | $90.51 | +4.64% | 2 qtrssince 2022-Q4 | Increased 56 |
ISHR IBX USD HIYLD CB ETF-UI | 2.5M | $188.9M | 2.9% | — | — | — | Increased — |
| 137.2M | $167M | 2.6% | — | — | — | Decreased 0 | |
| 206.5M | $162.3M | 2.5% | — | — | — | Increased 61 | |
ALPHABET INC-CL A | 1.4M | $147.2M | 2.3% | $93.01 | +7.65% | 16 qtrssince 2019-Q2 | Decreased 0 |
| 152.2M | $139.2M | 2.1% | — | — | — | Decreased 0 | |
HORIZON THERAPEUTICS PLC | 1.3M | $138.9M | 2.1% | — | — | — | New — |
| 159.7M | $137.3M | 2.1% | — | — | — | Increased 60 | |
FIRST HORIZON CORPORATION | 7.3M | $130M | 2.0% | $21.88 | +18.92% | 2 qtrssince 2022-Q4 | Decreased 0 |
| 161.5M | $125.9M | 1.9% | — | — | — | Unchanged 0 | |
| 146M | $123.4M | 1.9% | — | — | — | Increased 53 | |
LIBERTY BROADBAND C-W/I | 1.4M | $113.6M | 1.8% | $67.30 | +11.22% | 18 qtrssince 2018-Q4 | Unchanged 0 |
| 126.5M | $111.8M | 1.7% | — | — | — | Increased 52 | |
| 115.3M | $107.2M | 1.7% | — | — | — | Unchanged 0 | |
| 134.5M | $106.9M | 1.6% | — | — | — | Decreased 0 | |
INVESCO QQQ TRUST SERIES 1 CL USD INC | 330,000 | $105.9M | 1.6% | — | — | — | Decreased — |
| 119M | $101.4M | 1.6% | — | — | — | Decreased 0 | |
| 152.5M | $100.8M | 1.6% | — | — | — | Decreased 0 | |
| 112M | $99.3M | 1.5% | — | — | — | Increased 61 |
SOROS FUND MANAGEMENT LLC manages $6.5B across 185 positions as of Q1 2023. Top holdings: HZNP (5.5%), LQD (4.1%), HYG (2.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 45 new positions, 61 exits, 28 increased. Top move: HZNP (INCREASED, conviction 69). Portfolio: $6.5B across 185 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer